BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35708126)

  • 1. Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study.
    Lazzarotto A; Tonietto M; Poirion E; Battaglini M; Palladino R; Benoit C; Ricigliano VA; Maillart E; De Stefano N; Stankoff B; Bodini B
    Mult Scler; 2022 Oct; 28(12):1881-1890. PubMed ID: 35708126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal partial volume correction: Application to [
    Grecchi E; Veronese M; Bodini B; García-Lorenzo D; Battaglini M; Stankoff B; Turkheimer FE
    J Cereb Blood Flow Metab; 2017 Dec; 37(12):3803-3817. PubMed ID: 28569617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
    Tonietto M; Poirion E; Lazzarotto A; Ricigliano V; Papeix C; Bottlaender M; Bodini B; Stankoff B
    Brain; 2023 Jan; 146(1):182-194. PubMed ID: 36097347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of demyelinated lesions in a multiple sclerosis model using ultrashort echo time magnetization transfer (UTE-MT) imaging.
    Guglielmetti C; Boucneau T; Cao P; Van der Linden A; Larson PEZ; Chaumeil MM
    Neuroimage; 2020 Mar; 208():116415. PubMed ID: 31811900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
    Lazzarotto A; Hamzaoui M; Tonietto M; Dubessy AL; Khalil M; Pirpamer L; Ropele S; Enzinger C; Battaglini M; Stromillo ML; De Stefano N; Filippi M; Rocca MA; Gallo P; Gasperini C; Stankoff B; Bodini B;
    Brain; 2024 Apr; 147(4):1331-1343. PubMed ID: 38267729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosis.
    Ricigliano VAG; Tonietto M; Hamzaoui M; Poirion É; Lazzarotto A; Bottlaender M; Gervais P; Maillart E; Stankoff B; Bodini B
    Eur J Neurol; 2022 Jun; 29(6):1719-1729. PubMed ID: 35152511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis.
    Wei W; Poirion E; Bodini B; Tonietto M; Durrleman S; Colliot O; Stankoff B; Ayache N
    Neuroimage; 2020 Dec; 223():117308. PubMed ID: 32889117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.
    Brown RA; Narayanan S; Arnold DL
    Neuroimage Clin; 2014; 6():20-5. PubMed ID: 25610760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis.
    Bodini B; Veronese M; García-Lorenzo D; Battaglini M; Poirion E; Chardain A; Freeman L; Louapre C; Tchikviladze M; Papeix C; Dollé F; Zalc B; Lubetzki C; Bottlaender M; Turkheimer F; Stankoff B
    Ann Neurol; 2016 May; 79(5):726-738. PubMed ID: 26891452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
    Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA
    Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination.
    Huitema MJD; Strijbis EMM; Luchicchi A; Bol JGJM; Plemel JR; Geurts JJG; Schenk GJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Dimensional Lesion Phenotyping and Physiologic Characterization Inform Remyelination Ability in Multiple Sclerosis.
    Sivakolundu DK; Hansen MR; West KL; Wang Y; Stanley T; Wilson A; McCreary M; Turner MP; Pinho MC; Newton BD; Guo X; Rypma B; Okuda DT
    J Neuroimaging; 2019 Sep; 29(5):605-614. PubMed ID: 31148298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative magnetic resonance imaging reflects different levels of histologically determined myelin densities in multiple sclerosis, including remyelination in inactive multiple sclerosis lesions.
    Wiggermann V; Endmayr V; Hernández-Torres E; Höftberger R; Kasprian G; Hametner S; Rauscher A
    Brain Pathol; 2023 Nov; 33(6):e13150. PubMed ID: 36720269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. q-Space Myelin Map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: A preliminary study.
    Tanikawa M; Nakahara J; Hata J; Suzuki S; Fujiyoshi K; Fujiwara H; Momoshima S; Jinzaki M; Nakamura M; Okano H; Takahashi S; Suzuki N
    J Neurol Sci; 2017 Feb; 373():352-357. PubMed ID: 28088313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial.
    Caverzasi E; Papinutto N; Cordano C; Kirkish G; Gundel TJ; Zhu A; Akula AV; Boscardin WJ; Neeb H; Henry RG; Chan JR; Green AJ
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2217635120. PubMed ID: 37155847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions.
    Kolb H; Absinta M; Beck ES; Ha SK; Song Y; Norato G; Cortese I; Sati P; Nair G; Reich DS
    Ann Neurol; 2021 Oct; 90(4):612-626. PubMed ID: 34390015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
    de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
    Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis.
    de Paula Faria D; Real CC; Estessi de Souza L; Teles Garcez A; Navarro Marques FL; Buchpiguel CA
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic correlates of the magnetization transfer ratio in multiple sclerosis.
    Moccia M; van de Pavert S; Eshaghi A; Haider L; Pichat J; Yiannakas M; Ourselin S; Wang Y; Wheeler-Kingshott C; Thompson A; Barkhof F; Ciccarelli O
    Neurology; 2020 Dec; 95(22):e2965-e2976. PubMed ID: 32938787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
    Zhang Y; Jonkman L; Klauser A; Barkhof F; Yong VW; Metz LM; Geurts JJ
    Mult Scler; 2016 Oct; 22(12):1569-1577. PubMed ID: 26754802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.